DDS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Dillard's Inc. (DDS) is not a strong buy for a beginner, long-term investor at this time. While the company has shown modest financial growth and bullish technical indicators, the lack of significant positive catalysts, limited earnings growth potential as per analysts, and neutral trading sentiment suggest a hold position is more appropriate.
The technical indicators are moderately bullish. The MACD histogram is positive and expanding, suggesting upward momentum. The RSI is neutral at 55.292, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level of 638.503, with resistance levels at R1: 667.253 and R2: 685.014.
The company's financial performance in Q3 2026 showed modest growth: Revenue increased by 2.74% YoY, Net Income grew by 4.18% YoY, and EPS rose by 7.50% YoY. Gross Margin also improved to 41.25%. Technical indicators are bullish, and the stock has a 3.52% chance of increasing in the next month.
Analysts have a bearish outlook, with UBS and JPMorgan maintaining Sell and Underweight ratings, respectively, citing limited earnings growth potential. There is no recent news or significant trading trends from hedge funds, insiders, or Congress. Additionally, the stock has a 60% chance of declining in the next week (-3.63%).
In Q3 2026, Dillard's reported Revenue of $1.49B (+2.74% YoY), Net Income of $129.81M (+4.18% YoY), EPS of 8.31 (+7.50% YoY), and a Gross Margin of 41.25% (+1.83% YoY). These figures indicate modest growth across key financial metrics.
UBS raised the price target to $460 from $184 but maintained a Sell rating, citing limited earnings growth potential. JPMorgan raised the price target to $524 from $411 but kept an Underweight rating. Analysts remain bearish overall, seeing limited upside for the stock.
